SLS Sellas Life Sciences group - arbitrator dismisses company's claims in arbitration against 3d Medicines on July 24, 2026 - SEC filing - C
SLS Sellas Life Sciences group - arbitrator dismisses company's claims in arbitration against 3d Medicines on July 24, 2026 - SEC filing - Company to pay about $1M of 3d Medicines' legal fees - SEC filing
Story updates
08:39:07 PM UTC
SquawkNews
SLS Sellas Life Sciences group - arbitrator dismisses company's claims in arbitration against 3d Medicines on July 24, 2026 - SEC filing - Company to pay about $1M of 3d Medicines' legal fees - SEC filing Sellas Life Sciences group Inc: 3d Medicines will continue development & commercialization of g
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.